Entry Detail



General Information

Database ID:exR0000436
RNA Name:AKAP10
RNA Type:mRNA
Chromosome:chr17
Starnd:-
Coordinate:
Start Site(bp):19904302End Site(bp):19978343
External Links:ENSG00000108599



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
TCERG1
chr5
146447311
146511961
+
EFNB2
chr13
106489745
106535662
-
MCFD2
chr2
46901870
46941855
-
ZNF850
chr19
36714383
36772825
-
ATP5MC2
chr12
53632726
53677408
-
PTPRF
chr1
43525187
43623666
+
NSMF
chr9
137447573
137459334
-
GUF1
chr4
44678420
44700928
+
AMPD2
chr1
109616104
109632053
+
MTG2
chr20
62183029
62203568
+
AASDHPPT
chr11
106075501
106098699
+
PROM1
chr4
15963076
16084378
-
RPL27
chr17
42998273
43002959
+
MICALL1
chr22
37905657
37942822
+
ZNF24
chr18
35332227
35345482
-
CSNK1E
chr22
38290691
38318084
-
ICMT
chr1
6221193
6235972
-
ZFAND3
chr6
37819727
38154624
+
SBNO2
chr19
1107637
1174268
-
OGT
chrX
71533104
71575892
+
FOXK2
chr17
82519713
82644662
+
CANX
chr5
179678628
179731641
+
VMP1
chr17
59707192
59842255
+
CREBL2
chr12
12611827
12645108
+
GIGYF2
chr2
232697299
232860575
+
TNFSF9
chr19
6531026
6535924
+
SOBP
chr6
107490106
107661306
+
AP2A2
chr11
924894
1012245
+
SLC35F2
chr11
107790991
107928293
-
AP002990.1
chr11
62559603
62591531
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-130a-3p
chr11
57641252
57641273
+
hsa-miR-130b-3p
chr22
21653354
21653375
+
hsa-miR-454-3p
chr17
59137787
59137809
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC079949.1
chr12
127142029
127146532
-
AL645608.1
chr1
1011997
1013193
-
TMEM147-AS1
chr19
35540738
35546029
-
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.